W. Guo
Eli Lilly (United States) · 8 works · 314 citations · h-index 5
Top works
- Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain
- High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation
- Antinociceptive Pharmacology of N-[[4-(4,5-Dihydro-1 H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, Fumarate (LF22-0542), a Novel Nonpeptidic Bradykinin B1 Receptor Antagonist
- The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats
- Pharmacological interrogation of a rodent forced ambulation model: leveraging gait impairment as a measure of pain behavior pre-clinically
- Erratum to “glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain”
- Small-diameter covered stents do not affect efficacy but reduce hepatic encephalopathy in transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhosis
- (211) CB2 agonists reduce carrageenan-induced thermal hyperalgesia and edema in mice via a non-CB2 receptor mechanism